(Q35115896)

6 August 2017

title

Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer (English)

1 reference

inflammatory breast cancer

6 August 2017

0 references

1 reference

1 reference

1

Catherine Schairer

1 reference

6 August 2017

Linda M Brown

2

1 reference

6 August 2017

Phuong L Mai

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

9 March 2011

1 reference

Breast Cancer Research and Treatment

6 August 2017

published in

1 reference

6 August 2017

volume

129

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

117-124

1 reference

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Gene expression profiling of inflammatory breast cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Biology and management of inflammatory breast cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Relation of risk of contralateral breast cancer to the interval since the first primary tumour

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Second primary breast cancer occurrence according to hormone receptor status

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Contralateral prophylactic mastectomy for patients with unilateral breast cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Epidemiology of inflammatory breast cancer (IBC).

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Prophylactic mastectomy for the prevention of breast cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Molecular pathogenesis of bilateral breast cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Inflammatory breast cancer: a review

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer

9 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-010-1324-Y

Reproductive history and risk of second primary breast cancer: the WECARE study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-010-1324-Y

Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-010-1324-Y

Risk of second breast cancer according to estrogen receptor status and family history.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139759

Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21390499

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21390499

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Descriptive Epidemiology of Second Primary Breast Cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21390499

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10549-010-1324-Y

1 reference

6 August 2017

1 reference

6 August 2017

1 reference